Current status: 932 hESC lines, 4341 hiPSC lines, and 121 clinical studies, and 1119 certificates
Monthly statistic from Aug 1, 2023
Posted on August 1, 2023
| total lines | 5273 |
| hESC lines | 932 |
| hiPSC lines | 4341 |
| derivation countries | 46 |
| projects | 276 |
| providers | 829 |
| clinical studies | 121 |
| subclones | 2224 |
| certificates | 1119 |
| cell line certificates | 980 |
| project certificates | 139 |